Rollins (NYSE:ROL) reported quarterly earnings of $0.20 per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $714.00 million which beat the analyst consensus estimate of $686.33 million by 4.03 percent. This is a 11.88 percent increase over sales of $638.20 million the same period last year.
Here’s How Much You Would Have Made Owning Madrigal Pharmaceuticals Stock In The Last 5 Years
Madrigal Pharmaceuticals (NASDAQ:MDGL) has outperformed the market over the past 5 years by 14.88% on an annualized basis…
